Louisiana’s Department of Health confirms the state has received its most recent federal allotment of COVID-19 therapeutics, including 7,594 doses of drugs recently receiving Food and Drug Administration emergency use authorization to treat the virus. The shipments dated Feb 21-27 include the long-acting antibody combination Evusheld, monoclonal antibody treatments bebtelovimab and sotrovimab, as well as antiviral pills molnupiravir and paxlovid....
